When you think about vaccines, you may not think about the need for them later in life, but vaccines for older Americans are a critical component of maintaining health as you age. According to the Centers for Disease Control and Prevention, our immune systems weaken over time, which puts older Americans at higher risk for certain diseases. Important vaccines for older Americans include the flu, tetanus, hepatitis A and B, pertussis (whooping cough), pneumococcal, meningococcal, shingles and more.
An informed consumer is an engaged and empowered patient. With the right information, consumers are well equipped to be active participants in making decisions about their health care. But it isn’t always that simple. Consumers often face barriers when it comes to finding information about their insurance benefits and out-of-pocket costs. By removing these barriers, we can engage and empower patients to make better-informed decisions about their health care. Here are four ways to do this:
New National Health Expenditure (NHE) projections released today by the Centers for Medicare & Medicaid Services reaffirm how our nation’s competitive marketplace for medicines controls costs while supporting the development of new treatments and cures for patients.
In the age of personalized medicine, biomarkers are emerging as important tools in drug development. A biomarker is a measure or physical sign that can be used to determine how the body is functioning. This can help researchers develop more individualized treatments, provide an early warning sign for certain health risks and accelerate the availability of new medicines for patients.
Over 35 years ago, leaders in Washington D.C. united in what would today be a strikingly bipartisan manner to pass the University and Small Business Patent Procedures Act of 1980 – better known as the Bayh-Dole Act. The legislation created a framework for technology transfer that helped rejuvenate the American economy and continues to be a model for the rest of the world. A new paper, “How the Bayh-Dole Act Propelled U.S. Global Leadership in the Life Sciences”, focuses on the contributions of the Act in fostering technology transfer.
The Institute for Clinical and Economic Review (ICER) has set its sights on a new target: life-saving treatments for advanced non-small cell lung cancer (NSCLC).
ICER’s latest draft scoping document outlines what it will cover in its forthcoming report assessing treatments for advanced NSCLC. According to the scoping document, ICER’s evidence report will assess several categories of lung cancer treatments, including tyrosine kinase inhibitors (TKIs) and immunotherapies. The value of these treatments in the fight against NSCLC, which accounts for 85 to 90 percent of all lung cancer diagnoses, has been widely recognized.
In the past, we’ve taken a closer look at the Medicare Part D Extra Help program and how it supports patients like Diane and Mateo – two hypothetical, low-income Medicare patients over the age of 65. But how might the program support a patient who is only 31?
On AccessBetterCoverage.org, we’ve been highlighting the growing challenges of insurance benefit design and the impact of high deductibles and out-of-pocket costs on patients.
Last week in The Wall Street Journal, Drew Altman of the Kaiser Family Foundation laid out the next big debate in health care: adequacy of coverage. (We’ve been talking about this for a while.) An earlier Kaiser analysis found patient spending on deductibles and coinsurance is rising faster than insurers’ own costs. So even as more Americans than ever have health insurance, how is cost sharing impacting families? Altman asserts larger deductibles can be “a significant burden for many family budgets and a barrier to care for the chronically ill.”
Just a few weeks ago in Havana, Colombia’s President Juan Manuel Santos and Commander of the Revolutionary Armed Forces of Colombia or FARC, Timoleon Jimenez, made history when they signed a peace agreement brokered by Cuba’s President Raul Castro.
Chances are you’ve heard a friend or loved one talk about their difficulty with affordable access to their medicines at the pharmacy. Maybe even you have struggled yourself. But the Partnership for Prescription Assistance – or PPA – is committed to helping.